02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(2003): Chodorowska G+, Ann Univ Mariae Curie Sklodowska<br />

[Med] 58(2), 7<br />

(1993): Wolkenstein P+, JAmAcadDermatol28, 66<br />

(1992): Baars JW+, Ann Oncol 3, 243<br />

Vasculitis<br />

(2003): Chodorowska G+, Ann Univ Mariae Curie Sklodowska<br />

[Med] 58(2), 7<br />

Vitiligo<br />

(1996): Rosenberg SA+, J Immunother Emphasis Tumor Immunol<br />

19, 81<br />

(1995): Wolkenstein P+, Arch Dermatol 130, 890<br />

(1994): Scheibenbogen C+, Eur J Cancer (30A) 8, 1209<br />

Xerosis (15%)<br />

Mucosal<br />

Aphthous stomatitis<br />

(1987): Gaspari AA+, JAMA 258, 1624 (5%)<br />

Glossitis<br />

(1987): Gaspari AA+, JAMA 258, 1624 (30%)<br />

Oral mucosal eruption<br />

(1989): Kerker BJ+, Semin Dermatol 8, 173<br />

(1987): Gaspari AA+, JAMA 258, 1624<br />

Oral ulceration<br />

(1990): Chien CH+, Pediatrics 86, 937<br />

Stomatitis (32%)<br />

Xerostomia<br />

(2001): Chi KH+, Oncology 60, 110<br />

Hair<br />

Hair – alopecia (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!